Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients

Methods and Results:  Oxidative stress was examined in 19 erythropoietin‐treated haemodialysis patients who were receiving 100 mg of iron sucrose every 2 weeks by two intravenous methods, rapid injection and slow infusion. There were no significant differences in incidence of iron oversaturation state between the two methods. Regarding oxidative stress markers, the values of plasma and red blood cell thiobarbituric acid reactive substances (TBARS) expressed in terms of malonyldialdehyde (MDA) equivalents following the two methods did not increase, and the values of area under the curve (AUC) of both markers were not different between both regimens. Also, there were no significant differences in the values of plasma and AUC of anti‐oxidant markers including total anti‐oxidant status, reduced thiols, and vitamin E among both periods treated with two intravenous iron methods.